Analyst Ratings for RxSight Inc. (RXST)
RXST Rating Summary
RXST Price Target Summary
- Highest: $11.50 (Jefferies)
- Lowest: $6.50 (BofA Securities)
- Average: $9.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.33 (+68.2%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
Avg. $ Target:
$9.33 (+68.2%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/30/2026 | William Blair | Steven Lichtman | New Coverage | Market Perform (N/A) |
N/A (N/A) |
8.91 (5.55) |
-37.71% | Details |
| 7/15/2025 | Morgan Stanley » Updated 12/2/2025 |
Patrick Wood | Downgrade | Equalweight (Overweight) |
10.00 (9.00) |
7.74 (5.55) |
-28.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
